Set the Record Straight With Menopausal Hormone Therapy
February 2026
Patients will ask you about menopausal hormone therapy (MHT)...due to FDA removing certain risks (breast cancer, etc) from boxed warnings.
Note that the endometrial cancer warning will stay for estrogen-only products. Ensure a progestogen or bazedoxifene is on board for patients with a uterus...to reduce endometrial hyperplasia risk.
Be ready to discuss what’s a rumor and what’s true.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote